Optimizing Bioink Composition for Human Chondrocyte Expression of Lubricin.

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Biotechnology

Background:

• Articular cartilage defects, often leading to osteoarthritis, initially impact the surface zone.
• Chondrocytes in this zone produce lubricin, a proteoglycan essential for joint lubrication and protection against shear stress.
• 3D bioprinting offers a promising approach for cartilage tissue engineering, utilizing cells within biomaterials.

Purpose of the Study:

• To identify an optimal combination of GelMA and OMA biomaterials for maximizing lubricin expression in 3D bioprinted cartilage constructs.
• To develop and validate a high-throughput screening system for assessing chondrocyte reporter gene expression within biomaterial formulations.

Main Methods:

• A novel human articular chondrocyte reporter system was developed, using PRG4 promoter-driven Gaussia luciferase for temporal lubricin expression monitoring.
• A Design of Experiments (DoE) approach was employed to screen various GelMA and OMA concentrations.
• Optimized formulations, including 14% GelMA/2% OMA, 14% GelMA control, and 16% GelMA control, were 3D bioprinted and cultured for 22 days.

Main Results:

• The DoE screen identified 14% GelMA/2% OMA as a promising formulation for enhanced lubricin expression.
• 3D bioprinted constructs using 14% GelMA/2% OMA demonstrated superior lubricin protein secretion compared to controls.
• This formulation also exhibited good shape retention over the 22-day culture period.

Conclusions:

• The 14% GelMA/2% OMA formulation is optimal for 3D bioprinting of articular cartilage, promoting significant lubricin secretion.
• This strategy enables rapid evaluation of biomaterial properties on chondrocyte function, potentially advancing cartilage regeneration therapies.
• The findings support the development of improved therapeutic strategies for cartilage defects and osteoarthritis treatment.